Home › Relapsing-Remitting Multiple Sclerosis › Wisconsin
Relapsing-Remitting Multiple Sclerosis clinical trials in Wisconsin
3 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in Wisconsin.
Cities in Wisconsin
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- Medical College of Wisconsin, Milwaukee
Recruiting
Ages 22 to 60 · All sexes · Updated Sep 2, 2026 · NCT06796504From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.